Loss-of-function mutations in the histone methyltransferase EZH2 promote chemotherapy resistance in AML.
Kempf JM, Weser S, Bartoschek MD, Metzeler KH, Vick B, Herold T, Völse K, Mattes R, Scholz M, Wange LE, Festini M, Ugur E, Roas M, Weigert O, Bultmann S, Leonhardt H, Schotta G, Hiddemann W, Jeremias I, Spiekermann K.
Kempf JM, et al. Among authors: leonhardt h.
Sci Rep. 2021 Mar 12;11(1):5838. doi: 10.1038/s41598-021-84708-6.
Sci Rep. 2021.
PMID: 33712646
Free PMC article.